Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy

PR Newswire
1 Min Read

TAIPEI and SAN DIEGO, Oct. 20, 2025 /PRNewswire/ — Senhwa Biosciences’s investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant’s biological artificial intelligence (AI) system….

​TAIPEI and SAN DIEGO, Oct. 20, 2025 /PRNewswire/ — Senhwa Biosciences’s investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant’s biological artificial intelligence (AI) system….  ​All Consumer Technology

Share This Article
PR Newswire is the storytelling engine behind thousands of corporate announcements worldwide. With a rich legacy in media distribution, it helps brands turn their updates into meaningful narratives by connecting them with journalists, investors, and audiences who shape global conversations. Through trusted networks and data-backed distribution, PR Newswire ensures every story reaches the people who matter most.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *